Insider filing
Traded Dec 12, 2025 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 21, 2025 · Filed Nov 21, 2025
A Sensus Healthcare director paid $28K out of pocket for Sensus Healthcare shares. 2 other people at Sensus Healthcare bought some too, in the same month. Shares held went up 5% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$27,510
Shares × reported transaction price
$25K–$100K
+5.3%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 1 earlier confirmed purchase
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
15 days after results of Nov 6, 2025, 83 days before results of Feb 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $4.02 on Nov 21, 2025, 30% above its 52-week low and 55% below its high, after a 23% rise over the previous 30 trading days
52-week range $3.09 (Sep 17, 2025) to $8.99 (Feb 5, 2025), 16% of the way up, from 250 adjusted closes. 30 trading days earlier: $3.28 on Oct 10, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
3 SRTS insiders bought within the same week. That happened once before in filings since 2016: May 2023
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −0.5% | +1.7% | −2.2% |
| 30 days | −5.7% | +3.2% | −9.0% |
| 90 days | −5.0% | +2.0% | −7.0% |
| 180 days | −20.4% | +12.2% | −32.6% |
Past results only. Not a forecast.
Insider filing
Traded Dec 12, 2025 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
Their first buy on recordTraded Nov 13, 2025 · filed 7 days later
A Sensus Healthcare director paid $11K out of pocket for Sensus Healthcare shares. 2 other people at Sensus Healthcare bought some too, in the same month.
Insider buying
3 insiders in a week, 2nd time since 2016Traded Nov 18, 2025 · filed 1 day later
A Sensus Healthcare director paid $3.8K out of pocket for Sensus Healthcare shares. 2 other people at Sensus Healthcare bought some too, in the same month.
Eric Sachetta, Director's past purchases, 90 days after disclosure: 4 buys, median −10.5 pts vs S&P 500, beat it 0 of 4 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.